On January 28th, 2025, the Trump administration signed an executive order aimed at restricting federal support for gender-affirming medical treatments for people under the age of 19. The directive affects funding and insurance coverage by federal programs for procedures and therapies commonly described as “gender-affirming care.” Major U.S. medical associations oppose the order, while supporters cite the administration’s stance on parental rights and health policy. The order has been challenged in court and faces ongoing debate among lawmakers and advocacy groups.
